Browsing by author "Rutkowski, Piotr"
Sort by:
Title A-Z
-
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib
Lee, Chee Khoon; Goldstein, David; Gibbs, Emma; Joensuu, Heikki; Zalcberg, John; Verweij, Jaap; Casali, Paolo G; Maki, Robert G; Cioffi, Angela; McArthur, Grant; Lord, Sarah J; Yip, Desmond; Kanjanapan, Yada; Rutkowski, PiotrPublished 2015-03-19Purpose Metastatic gastrointestinal stromal tumor (GIST) is generally an incurable disease with variable response to imatinib. We aimed to develop prognostic nomograms to predict overall survival (OS) and progression-free ...Open AccessArticle -
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial
Luke, Jason J; Rutkowski, Piotr; Queirolo, Paola; Del Vecchio, Michele; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; de la Cruz Merino, Luis; Khattak, Muhammad A; Schadendorf, Dirk; Long, Georgina V; Ascierto, Paolo A; Mandala, Mario; De Galitiis, Federica; Haydon, Andrew; Dummer, Reinhard; Grob, Jean-Jacques; Robert, Caroline; Carlino, Matteo S; Mohr, Peter; Poklepovic, Andrew; Sondak, Vernon K; Scolyer, Richard A; Kirkwood, John M; Chen, Ke; Diede, Scott J; Ahsan, Sama; Ibrahim, Nageatte; Eggermont, Alexander M M; Investigators, KEYNOTE-716Published 2022Background Pembrolizumab prolongs progression-free and overall survival among patients with advanced melanoma and recurrence-free survival in resected stage III disease. KEYNOTE-716 assessed pembrolizumab as adjuvant ...Article -
Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas
Casali, Paolo; Le Cesne, Axel; Velasco, Andres Poveda; Kotasak, Dusan; Rutkowski, Piotr; Hohenberger, Peter; Fumagalli, Elena; Judson, Ian; Italiano, Antoine; Gelderblom, Hans; Antoine, Adenis; Hartmann, Jorg; Duffaud, Florence; Goldstein, David; Broto, Javier; Gronchi, Alessandro; Dei Tos, Angelo; Marreaud, Sandrine; van der Graff, Winette; Zalcberg, John; Litiere, Saskia; Blay, Jean-YvesPublished 2015-12-01Purpose In 2004, we started an intergroup randomized trial of adjuvant imatinib versus no further therapy after R0-R1 surgery patients with localized, high- or intermediate-risk GI stromal tumor (GIST). Patients and Methods ...Open AccessArticle
Sort by:
Title A-Z